BioSig Technologies Inc. has completed a strategic merger with Streamex, transitioning from a medical technology company to a digital asset infrastructure company with a focus on tokenized gold.

BioSig Technologies Inc presents a paradox, with innovative solutions for cardiac catheter ablations, but also significant financial instability and market volatility.

BioSig Technologies Inc. has expanded into real-world asset (RWA) tokenization through the acquisition of a FINRA/SEC-registered broker-dealer, marking a strategic pivot for the medical technology company.

BioSig Technologies Inc. has expanded into the blockchain and financial technology sectors through strategic acquisitions and partnerships, aiming to diversify its offerings and capitalize on emerging trends in digital assets.

BioSig Technologies, Inc. is a pioneering company in the field of cardiac care, utilizing cutting-edge signal processing solutions to enhance patient outcomes and drive innovation in medical technology.

BioSig Technologies, Inc. is a pioneering force in medical technology, advancing cardiac care through innovative signal processing solutions that enhance catheter ablation procedures and improve patient outcomes.

BioSig Technologies has announced a strategic merger with Streamex, expanding its operations into asset tokenization and leading to a surge in its stock price.

BioSig Technologies, Inc. has entered into merger talks with Streamex Exchange Corp. in a move that could impact the company’s future operations and valuation.

BioSig Technologies Inc. is merging with Streamex Exchange Corp. to create a publicly listed real-world asset tokenization company, combining BioSig’s healthcare tech expertise with Streamex’s commodity tokenization infrastructure.